Title | Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC 750008, IND 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma |
---|---|
Disease/Condition | Pediatric Hematology/Oncology |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Lisa Figueiredo |
Contact Name | Joyce Brown |
Contact Email | joycbrow@montefiore.org |
IRB/Protocol Number | IRB# 2016-5998 |
Status | Enrolling |
Adult Clinical Trial | No |
Pediatric Clinical Trial | No |